Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 4
2022 5
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.
Tarrés-Freixas F, Aguilar-Gurrieri C, Rodríguez de la Concepción ML, Urrea V, Trinité B, Ortiz R, Pradenas E, Blanco P, Marfil S, Molinos-Albert LM, Barajas A, Pons-Grífols A, Ávila-Nieto C, Varela I, Cervera L, Gutiérrez-Granados S, Segura MM, Gòdia F, Clotet B, Carrillo J, Blanco J. Tarrés-Freixas F, et al. NPJ Vaccines. 2023 Apr 6;8(1):51. doi: 10.1038/s41541-023-00648-4. NPJ Vaccines. 2023. PMID: 37024469 Free PMC article.
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
Barajas A, Amengual-Rigo P, Pons-Grífols A, Ortiz R, Gracia Carmona O, Urrea V, de la Iglesia N, Blanco-Heredia J, Anjos-Souza C, Varela I, Trinité B, Tarrés-Freixas F, Rovirosa C, Lepore R, Vázquez M, de Mattos-Arruda L, Valencia A, Clotet B, Aguilar-Gurrieri C, Guallar V, Carrillo J, Blanco J. Barajas A, et al. Among authors: tarres freixas f. J Transl Med. 2024 Jan 3;22(1):14. doi: 10.1186/s12967-023-04843-8. J Transl Med. 2024. PMID: 38172991 Free PMC article.
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity.
de Campos-Mata L, Trinité B, Modrego A, Tejedor Vaquero S, Pradenas E, Pons-Grífols A, Rodrigo Melero N, Carlero D, Marfil S, Santiago C, Raïch-Regué D, Bueno-Carrasco MT, Tarrés-Freixas F, Abancó F, Urrea V, Izquierdo-Useros N, Riveira-Muñoz E, Ballana E, Pérez M, Vergara-Alert J, Segalés J, Carolis C, Arranz R, Blanco J, Magri G. de Campos-Mata L, et al. Among authors: tarres freixas f. Nat Commun. 2024 Feb 5;15(1):1051. doi: 10.1038/s41467-024-45171-9. Nat Commun. 2024. PMID: 38316751 Free PMC article.
β-Cyclodextrins as affordable antivirals to treat coronavirus infection.
Raïch-Regué D, Tenorio R, Fernández de Castro I, Tarrés-Freixas F, Sachse M, Perez-Zsolt D, Muñoz-Basagoiti J, Fernández-Sánchez SY, Gallemí M, Ortega-González P, Fernández-Oliva A, Gabaldón JA, Nuñez-Delicado E, Casas J, Roca N, Cantero G, Pérez M, Usai C, Lorca-Oró C, Alert JV, Segalés J, Carrillo J, Blanco J, Clotet Sala B, Cerón-Carrasco JP, Izquierdo-Useros N, Risco C. Raïch-Regué D, et al. Among authors: tarres freixas f. Biomed Pharmacother. 2023 Aug;164:114997. doi: 10.1016/j.biopha.2023.114997. Epub 2023 Jun 8. Biomed Pharmacother. 2023. PMID: 37311279 Free PMC article.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
Trinité B, Pradenas E, Marfil S, Rovirosa C, Urrea V, Tarrés-Freixas F, Ortiz R, Rodon J, Vergara-Alert J, Segalés J, Guallar V, Lepore R, Izquierdo-Useros N, Trujillo G, Trapé J, González-Fernández C, Flor A, Pérez-Vidal R, Toledo R, Chamorro A, Paredes R, Blanco I, Grau E, Massanella M, Carrillo J, Clotet B, Blanco J. Trinité B, et al. Among authors: tarres freixas f. Viruses. 2021 Jun 12;13(6):1135. doi: 10.3390/v13061135. Viruses. 2021. PMID: 34204754 Free PMC article.
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
Perez-Zsolt D, Muñoz-Basagoiti J, Rodon J, Elosua-Bayes M, Raïch-Regué D, Risco C, Sachse M, Pino M, Gumber S, Paiardini M, Chojnacki J, Erkizia I, Muñiz-Trabudua X, Ballana E, Riveira-Muñoz E, Noguera-Julian M, Paredes R, Trinité B, Tarrés-Freixas F, Blanco I, Guallar V, Carrillo J, Blanco J, Telenti A, Heyn H, Segalés J, Clotet B, Martinez-Picado J, Vergara-Alert J, Izquierdo-Useros N. Perez-Zsolt D, et al. Among authors: tarres freixas f. Cell Mol Immunol. 2021 Dec;18(12):2676-2678. doi: 10.1038/s41423-021-00794-6. Epub 2021 Nov 15. Cell Mol Immunol. 2021. PMID: 34782760 Free PMC article. No abstract available.
Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals.
Pradenas E, Ubals M, Urrea V, Suñer C, Trinité B, Riveira-Muñoz E, Marfil S, Ávila-Nieto C, Rodríguez de la Concepción ML, Tarrés-Freixas F, Laporte J, Ballana E, Carrillo J, Clotet B, Mitjà O, Blanco J. Pradenas E, et al. Among authors: tarres freixas f. Front Immunol. 2022 Apr 28;13:860215. doi: 10.3389/fimmu.2022.860215. eCollection 2022. Front Immunol. 2022. PMID: 35572570 Free PMC article.
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.
Ortiz R, Barajas A, Pons-Grífols A, Trinité B, Tarrés-Freixas F, Rovirosa C, Urrea V, Barreiro A, Gonzalez-Tendero A, Cardona M, Ferrer L, Clotet B, Carrillo J, Aguilar-Gurrieri C, Blanco J. Ortiz R, et al. Among authors: tarres freixas f. Int J Mol Sci. 2023 May 19;24(10):9025. doi: 10.3390/ijms24109025. Int J Mol Sci. 2023. PMID: 37240371 Free PMC article.
20 results